Cipla unit gets notice from US firm for termination of acquisition deal

"Since the second stage closing could not be completed as per the agreed timelines, in the terms of the SPMA, InvaGen has received a notice of termination from Avenue," the Mumbai-based drug major said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3q4e5Aa
via IFTTT